Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cisplatin-resistant neuroblastoma cells express enhanced levels of epidermal growth factor receptor (EGFR) and are sensitive to treatment with EGFR-specific toxins.
Michaelis M, Bliss J, Arnold SC, Hinsch N, Rothweiler F, Deubzer HE, Witt O, Langer K, Doerr HW, Wels WS, Cinatl J Jr. Michaelis M, et al. Among authors: rothweiler f. Clin Cancer Res. 2008 Oct 15;14(20):6531-7. doi: 10.1158/1078-0432.CCR-08-0821. Clin Cancer Res. 2008. PMID: 18927293 Free article.
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines.
Michaelis M, Kleinschmidt MC, Barth S, Rothweiler F, Geiler J, Breitling R, Mayer B, Deubzer H, Witt O, Kreuter J, Doerr HW, Cinatl J, Cinatl J Jr. Michaelis M, et al. Among authors: rothweiler f. Biochem Pharmacol. 2010 Jan 15;79(2):130-6. doi: 10.1016/j.bcp.2009.08.013. Epub 2009 Aug 19. Biochem Pharmacol. 2010. PMID: 19698702
Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles.
Wagner S, Rothweiler F, Anhorn MG, Sauer D, Riemann I, Weiss EC, Katsen-Globa A, Michaelis M, Cinatl J Jr, Schwartz D, Kreuter J, von Briesen H, Langer K. Wagner S, et al. Among authors: rothweiler f. Biomaterials. 2010 Mar;31(8):2388-98. doi: 10.1016/j.biomaterials.2009.11.093. Epub 2009 Dec 23. Biomaterials. 2010. PMID: 20031203
57 results